Business Description
IMCD NV
ISIN : NL0010801007
Compare
Compare
Traded in other countries / regions
IMCD.Netherlands0QVU.UKIMCDY.USAINX.GermanyIMCD.AustriaIMCD.Mexico IPO Date
2014-06-27Description
IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two categories: Life Science consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care and I&I, and The Industrial segment contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments; EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.31 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.74 | |||||
Debt-to-EBITDA | 2.25 | |||||
Interest Coverage | 8.57 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.73 | |||||
Beneish M-Score | -2.6 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.9 | |||||
3-Year EBITDA Growth Rate | 27.6 | |||||
3-Year EPS without NRI Growth Rate | 27.3 | |||||
3-Year FCF Growth Rate | 19.2 | |||||
3-Year Book Growth Rate | 11.2 | |||||
Future 3-5Y EPS without NRI Growth Rate | 15.59 | |||||
Future 3-5Y Total Revenue Growth Rate | 6.22 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.04 | |||||
9-Day RSI | 42.46 | |||||
14-Day RSI | 42.78 | |||||
6-1 Month Momentum % | -7.39 | |||||
12-1 Month Momentum % | -2.96 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.75 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.4 | |||||
Days Inventory | 67.29 | |||||
Days Sales Outstanding | 59.52 | |||||
Days Payable | 45.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.72 | |||||
Dividend Payout Ratio | 0.46 | |||||
3-Year Dividend Growth Rate | 38.1 | |||||
Forward Dividend Yield % | 1.72 | |||||
5-Year Yield-on-Cost % | 6.17 | |||||
Shareholder Yield % | 0.79 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 25.27 | |||||
Operating Margin % | 9.65 | |||||
Net Margin % | 6.58 | |||||
FCF Margin % | 8.61 | |||||
ROE % | 17.35 | |||||
ROA % | 7.46 | |||||
ROIC % | 9.95 | |||||
ROC (Joel Greenblatt) % | 99.24 | |||||
ROCE % | 15.91 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 25.58 | |||||
Forward PE Ratio | 20.79 | |||||
PE Ratio without NRI | 25.58 | |||||
Shiller PE Ratio | 46.14 | |||||
Price-to-Owner-Earnings | 13.85 | |||||
PEG Ratio | 1.08 | |||||
PS Ratio | 1.68 | |||||
PB Ratio | 4.33 | |||||
Price-to-Free-Cash-Flow | 19.52 | |||||
Price-to-Operating-Cash-Flow | 17.79 | |||||
EV-to-EBIT | 18.45 | |||||
EV-to-Forward-EBIT | 16.03 | |||||
EV-to-EBITDA | 14.74 | |||||
EV-to-Forward-EBITDA | 14.95 | |||||
EV-to-Revenue | 1.88 | |||||
EV-to-Forward-Revenue | 1.77 | |||||
EV-to-FCF | 21.66 | |||||
Price-to-Projected-FCF | 1.71 | |||||
Price-to-Median-PS-Value | 1.06 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.18 | |||||
Earnings Yield (Greenblatt) % | 5.42 | |||||
FCF Yield % | 5.11 | |||||
Forward Rate of Return (Yacktman) % | 23.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IMCD NV Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 4,442.642 | ||
EPS (TTM) (€) | 5.13 | ||
Beta | 1.56 | ||
Volatility % | 39.78 | ||
14-Day RSI | 42.78 | ||
14-Day ATR (€) | 2.637599 | ||
20-Day SMA (€) | 130.875 | ||
12-1 Month Momentum % | -2.96 | ||
52-Week Range (€) | 109.05 - 169.05 | ||
Shares Outstanding (Mil) | 56.95 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
IMCD NV Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
IMCD NV Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
IMCD NV Frequently Asked Questions
What is IMCD NV(XAMS:IMCD)'s stock price today?
The current price of XAMS:IMCD is €131.25. The 52 week high of XAMS:IMCD is €169.05 and 52 week low is €109.05.
When is next earnings date of IMCD NV(XAMS:IMCD)?
The next earnings date of IMCD NV(XAMS:IMCD) is .
Does IMCD NV(XAMS:IMCD) pay dividends? If so, how much?
The Dividend Yield %  of IMCD NV(XAMS:IMCD) is 1.72% (As of Today), Highest Dividend Payout Ratio of IMCD NV(XAMS:IMCD) was 0.5. The lowest was 0.15. And the median was 0.32. The  Forward Dividend Yield % of IMCD NV(XAMS:IMCD) is 1.72%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |